Scott S - Search Results

1

The radiation-inducible pE9 promoter driving inducible nitric oxide synthase radiosensitizes hypoxic tumour cells to radiation.

Coulter JA, McCarthy HO, Worthington J, Robson T, Scott S, Hirst DG. Coulter JA, et al. Among authors: scott s. Gene Ther. 2008 Apr;15(7):495-503. doi: 10.1038/gt.2008.7. Epub 2008 Feb 7. Gene Ther. 2008. PMID: 18256696

2

Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer.

Worthington J, Robson T, Scott S, Hirst D. Worthington J, et al. Among authors: scott s. Gene Ther. 2005 Oct;12(19):1417-23. doi: 10.1038/sj.gt.3302552. Gene Ther. 2005. PMID: 15902277

3

Development of synthetic promoters for radiation-mediated gene therapy.

Marples B, Scott SD, Hendry JH, Embleton MJ, Lashford LS, Margison GP. Marples B, et al. Among authors: scott sd. Gene Ther. 2000 Mar;7(6):511-7. doi: 10.1038/sj.gt.3301116. Gene Ther. 2000. PMID: 10757025

4

Novel chimeric gene promoters responsive to hypoxia and ionizing radiation.

Greco O, Marples B, Dachs GU, Williams KJ, Patterson AV, Scott SD. Greco O, et al. Among authors: scott sd. Gene Ther. 2002 Oct;9(20):1403-11. doi: 10.1038/sj.gt.3301823. Gene Ther. 2002. PMID: 12365006

5

Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy.

Scott SD, Joiner MC, Marples B. Scott SD, et al. Gene Ther. 2002 Oct;9(20):1396-402. doi: 10.1038/sj.gt.3301822. Gene Ther. 2002. PMID: 12365005

6

A radiation-controlled molecular switch for use in gene therapy of cancer.

Scott SD, Marples B, Hendry JH, Lashford LS, Embleton MJ, Hunter RD, Howell A, Margison GP. Scott SD, et al. Gene Ther. 2000 Jul;7(13):1121-5. doi: 10.1038/sj.gt.3301223. Gene Ther. 2000. PMID: 10918478

7

Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.

Greco O, Joiner MC, Doleh A, Powell AD, Hillman GG, Scott SD. Greco O, et al. Among authors: scott sd. Gene Ther. 2006 Feb;13(3):206-15. doi: 10.1038/sj.gt.3302640. Gene Ther. 2006. PMID: 16307003

8

A novel magnetic approach to enhance the efficacy of cell-based gene therapies.

Muthana M, Scott SD, Farrow N, Morrow F, Murdoch C, Grubb S, Brown N, Dobson J, Lewis CE. Muthana M, et al. Among authors: scott sd. Gene Ther. 2008 Jun;15(12):902-10. doi: 10.1038/gt.2008.57. Epub 2008 Apr 17. Gene Ther. 2008. PMID: 18418420

9

Gene therapy vectors containing CArG elements from the Egr1 gene are activated by neutron irradiation, cisplatin and doxorubicin.

Greco O, Powell TM, Marples B, Joiner MC, Scott SD. Greco O, et al. Cancer Gene Ther. 2005 Jul;12(7):655-62. doi: 10.1038/sj.cgt.7700834. Cancer Gene Ther. 2005. PMID: 15818381

10

VP22-mediated intercellular transport for suicide gene therapy under oxic and hypoxic conditions.

Greco O, Joiner MC, Doleh A, Scott SD. Greco O, et al. Among authors: scott sd. Gene Ther. 2005 Jun;12(12):974-9. doi: 10.1038/sj.gt.3302482. Gene Ther. 2005. PMID: 15729368

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,893 results

Search Page

Filters